Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    11087881 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Rofecoxib to Prevent Pain After Third Molar (Wisdom Tooth) Extraction
Condition: Pain
Intervention: Drug: Rofecoxib
2 Completed Celecoxib for the Treatment of Non-muscle Invasive Bladder Cancer
Condition: Non Muscle Invasive Bladder Cancer
Intervention: Drug: Celecoxib

Indicates status has not been verified in more than two years